selection

medicine

This tag is associated with 6 posts

A novel approach for better delivery of precision medicines in Europe

The STOA workshop entitled ‘Innovative solution for research in healthcare’, chaired by Paul Rübig (EPP, AT), first STOA Vice-Chair, is an opportunity to discuss the implementation of an ‘innovation-centred’ system, exploring a truly ‘patient-centred’ paradigm with systematically coordinated applied clinical research carried out in conjunction with drug development. Continue reading

Seniors using e-health services [What Europe does for you]

Did you know that 30 % of Europeans will be over 65 in 2060? Our population is ageing and the number of people with age-related impairments is expected to reach 84 million already in 2020. Continue reading

Therapies for the future – Advanced therapies & nanomedicine

Advanced therapy medicinal products constitute a heterogeneous group of biopharmaceuticals encompassing gene therapy and somatic cell therapy medicinal products, as well as tissue-engineered and combined products (tissues or cells associated with a device). Continue reading

Therapies for the future – Exploring the potential of innovative treatments in Europe

The purpose of this workshop is to report on the status of nanomaterial-based and advanced therapy medicinal products, as well as on possible pathways for the future development of these new therapies in Europe. Continue reading

Medicinal products in the European Union: The legal framework for medicines for human use

Written by Nicole Scholz A high level of protection for human health is a central objective of European Union (EU) public health policy. To guarantee this objective, high standards of quality and safety for medicinal products are essential. Although pharmaceuticals are primarily regulated at the national level by the Member States, there is a large body of EU legislation … Continue reading

Control of swine fever in the EU

Classical swine fever (CSF) and African swine fever (ASF) are two highly transmissible viral diseases affecting domestic pigs and wild boar, with major economic consequences on pig farming and on pig-product markets. These diseases are not transmissible to humans. At global level, trans-border animal diseases fall under the remit of the World Animal Health Organisation. … Continue reading

Download the EPRS App

EPRS App on Google Play
EPRS App on App Store
What Europe Does For You
EU Legislation in Progress
Topical Digests
EPRS Podcasts

Enter your email address to follow this blog and receive notifications of new posts by email.

Join 3,035 other followers

Disclaimer and Copyright statement

The content of all documents (and articles) contained in this blog is the sole responsibility of the author and any opinions expressed therein do not necessarily represent the official position of the European Parliament. It is addressed to the Members and staff of the EP for their parliamentary work. Reproduction and translation for non-commercial purposes are authorised, provided the source is acknowledged and the European Parliament is given prior notice and sent a copy.

For a comprehensive description of our cookie and data protection policies, please visit Terms and Conditions page.

Copyright © European Union, 2014-2019. All rights reserved.